Toppgene analysis for Wikipedia protein communities, toppgene analysis, cc73_10, positive side

Go To Start Page
Input Parameters [Show Detail]
Training Results [Expand All] [Download All] [Sparse Matrix]
Display pValues and Scores as Table row limit

1: GO: Molecular Function [Display Chart] 10 input genes in category / 47 annotations before applied cutoff / 18661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0031707 endothelin A receptor binding 5.359E-4 2.517E-2
1.117E-1
 2.519E-2 1 1
2 GO:0004867 serine-type endopeptidase inhibitor activity 1.147E-3 2.517E-2
1.117E-1
5.392E-2
 2 96
3 GO:0031708 endothelin B receptor binding 1.607E-3 2.517E-2
1.117E-1
7.552E-2
 1 3
4 GO:0031705 bombesin receptor binding 2.142E-3 2.517E-2
1.117E-1
1.007E-1
 1 4
5 GO:0004866 endopeptidase inhibitor activity 3.579E-3 2.657E-2
1.179E-1
1.682E-1
 2 171
6 GO:0061135 endopeptidase regulator activity 3.829E-3 2.657E-2
1.179E-1
1.800E-1
 2 177
7 GO:0030414 peptidase inhibitor activity 3.957E-3 2.657E-2
1.179E-1
1.860E-1
 2 180
8 GO:0008429 phosphatidylethanolamine binding 4.814E-3 2.828E-2
1.255E-1
2.262E-1
 1 9
9 GO:0061134 peptidase regulator activity 5.954E-3 3.014E-2
1.338E-1
2.798E-1
 2 222
10 GO:0043024 ribosomal small subunit binding 6.413E-3 3.014E-2
1.338E-1
3.014E-1
 1 12
11 GO:0008191 metalloendopeptidase inhibitor activity 7.479E-3 3.195E-2
1.418E-1
3.515E-1
 1 14
12 GO:0019215 intermediate filament binding 8.543E-3 3.346E-2
1.485E-1
4.015E-1
 1 16
13 GO:0004550 nucleoside diphosphate kinase activity 1.014E-2 3.665E-2
1.627E-1
4.765E-1
 1 19
14 GO:0042923 neuropeptide binding 1.226E-2 4.116E-2
1.827E-1
5.762E-1
 1 23
15 GO:0043015 gamma-tubulin binding 1.438E-2 4.119E-2
1.828E-1
6.758E-1
 1 27
16 GO:0051019 mitogen-activated protein kinase binding 1.596E-2 4.119E-2
1.828E-1
7.503E-1
 1 30
17 GO:0071855 neuropeptide receptor binding 1.649E-2 4.119E-2
1.828E-1
7.751E-1
 1 31
18 GO:0005525 GTP binding 1.654E-2 4.119E-2
1.828E-1
7.773E-1
 2 378
19 GO:0004857 enzyme inhibitor activity 1.780E-2 4.119E-2
1.828E-1
8.367E-1
 2 393
20 GO:0032561 guanyl ribonucleotide binding 1.832E-2 4.119E-2
1.828E-1
8.610E-1
 2 399
21 GO:0019001 guanyl nucleotide binding 1.841E-2 4.119E-2
1.828E-1
8.651E-1
 2 400
22 GO:0016776 phosphotransferase activity, phosphate group as acceptor 2.334E-2 4.983E-2
2.211E-1
1.000E0
 1 44
23 GO:0008188 neuropeptide receptor activity 2.438E-2 4.983E-2
2.211E-1
1.000E0
 1 46
Show 18 more annotations

2: GO: Biological Process [Display Chart] 10 input genes in category / 676 annotations before applied cutoff / 18623 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0019932 second-messenger-mediated signaling 6.970E-6 4.712E-3 3.343E-2 4.712E-3 4 257
2 GO:0050804 modulation of chemical synaptic transmission 2.545E-5 8.603E-3
6.103E-2
 1.721E-2 4 357
3 GO:0050806 positive regulation of synaptic transmission 6.255E-5 1.409E-2
9.999E-2
 4.228E-2 3 153
4 GO:0032309 icosanoid secretion 2.002E-4 2.343E-2
1.662E-1
1.354E-1
 2 40
5 GO:0033574 response to testosterone 2.316E-4 2.343E-2
1.662E-1
1.566E-1
 2 43
6 GO:0071715 icosanoid transport 2.426E-4 2.343E-2
1.662E-1
1.640E-1
 2 44
7 GO:1901571 fatty acid derivative transport 2.426E-4 2.343E-2
1.662E-1
1.640E-1
 2 44
8 GO:0090068 positive regulation of cell cycle process 2.968E-4 2.355E-2
1.671E-1
2.007E-1
 3 259
9 GO:0045840 positive regulation of mitotic nuclear division 3.136E-4 2.355E-2
1.671E-1
2.120E-1
 2 50
10 GO:0071398 cellular response to fatty acid 3.659E-4 2.473E-2
1.755E-1
2.473E-1
 2 54
11 GO:0042313 protein kinase C deactivation 5.370E-4 2.842E-2
2.016E-1
3.630E-1
 1 1
12 GO:0060409 positive regulation of acetylcholine metabolic process 5.370E-4 2.842E-2
2.016E-1
3.630E-1
 1 1
13 GO:0051785 positive regulation of nuclear division 5.466E-4 2.842E-2
2.016E-1
3.695E-1
 2 66
14 GO:0045787 positive regulation of cell cycle 7.279E-4 3.437E-2
2.438E-1
4.921E-1
 3 352
15 GO:0035690 cellular response to drug 7.625E-4 3.437E-2
2.438E-1
5.155E-1
 2 78
16 GO:0015908 fatty acid transport 1.036E-3 3.557E-2
2.523E-1
7.003E-1
 2 91
17 GO:0070542 response to fatty acid 1.036E-3 3.557E-2
2.523E-1
7.003E-1
 2 91
18 GO:0043179 rhythmic excitation 1.074E-3 3.557E-2
2.523E-1
7.258E-1
 1 2
19 GO:0031583 phospholipase D-activating G protein-coupled receptor signaling pathway 1.074E-3 3.557E-2
2.523E-1
7.258E-1
 1 2
20 GO:0060408 regulation of acetylcholine metabolic process 1.074E-3 3.557E-2
2.523E-1
7.258E-1
 1 2
21 GO:0007200 phospholipase C-activating G protein-coupled receptor signaling pathway 1.105E-3 3.557E-2
2.523E-1
7.469E-1
 2 94
22 GO:0007589 body fluid secretion 1.376E-3 3.887E-2
2.758E-1
9.300E-1
 2 105
23 GO:0034696 response to prostaglandin F 1.610E-3 3.887E-2
2.758E-1
1.000E0
 1 3
24 GO:0070101 positive regulation of chemokine-mediated signaling pathway 1.610E-3 3.887E-2
2.758E-1
1.000E0
 1 3
25 GO:0060584 regulation of prostaglandin-endoperoxide synthase activity 1.610E-3 3.887E-2
2.758E-1
1.000E0
 1 3
26 GO:0030185 nitric oxide transport 1.610E-3 3.887E-2
2.758E-1
1.000E0
 1 3
27 GO:0060585 positive regulation of prostaglandin-endoperoxide synthase activity 1.610E-3 3.887E-2
2.758E-1
1.000E0
 1 3
28 GO:2000409 positive regulation of T cell extravasation 1.610E-3 3.887E-2
2.758E-1
1.000E0
 1 3
29 GO:0046717 acid secretion 1.972E-3 4.175E-2
2.962E-1
1.000E0
 2 126
30 GO:0002687 positive regulation of leukocyte migration 2.066E-3 4.175E-2
2.962E-1
1.000E0
 2 129
31 GO:1904684 negative regulation of metalloendopeptidase activity 2.146E-3 4.175E-2
2.962E-1
1.000E0
 1 4
32 GO:1905049 negative regulation of metallopeptidase activity 2.146E-3 4.175E-2
2.962E-1
1.000E0
 1 4
33 GO:0014826 vein smooth muscle contraction 2.146E-3 4.175E-2
2.962E-1
1.000E0
 1 4
34 GO:2000407 regulation of T cell extravasation 2.146E-3 4.175E-2
2.962E-1
1.000E0
 1 4
35 GO:0045931 positive regulation of mitotic cell cycle 2.162E-3 4.175E-2
2.962E-1
1.000E0
 2 132
36 GO:0051781 positive regulation of cell division 2.427E-3 4.558E-2
3.233E-1
1.000E0
 2 140
37 GO:0060298 positive regulation of sarcomere organization 2.682E-3 4.641E-2
3.292E-1
1.000E0
 1 5
38 GO:1904683 regulation of metalloendopeptidase activity 2.682E-3 4.641E-2
3.292E-1
1.000E0
 1 5
39 GO:0007088 regulation of mitotic nuclear division 2.743E-3 4.641E-2
3.292E-1
1.000E0
 2 149
40 GO:0046887 positive regulation of hormone secretion 2.853E-3 4.641E-2
3.292E-1
1.000E0
 2 152
41 GO:0003100 regulation of systemic arterial blood pressure by endothelin 3.218E-3 4.641E-2
3.292E-1
1.000E0
 1 6
42 GO:1905048 regulation of metallopeptidase activity 3.218E-3 4.641E-2
3.292E-1
1.000E0
 1 6
43 GO:0051771 negative regulation of nitric-oxide synthase biosynthetic process 3.218E-3 4.641E-2
3.292E-1
1.000E0
 1 6
44 GO:0060024 rhythmic synaptic transmission 3.218E-3 4.641E-2
3.292E-1
1.000E0
 1 6
45 GO:0090240 positive regulation of histone H4 acetylation 3.218E-3 4.641E-2
3.292E-1
1.000E0
 1 6
46 GO:0031032 actomyosin structure organization 3.233E-3 4.641E-2
3.292E-1
1.000E0
 2 162
47 GO:0019722 calcium-mediated signaling 3.272E-3 4.641E-2
3.292E-1
1.000E0
 2 163
48 GO:0015718 monocarboxylic acid transport 3.512E-3 4.641E-2
3.292E-1
1.000E0
 2 169
49 GO:0042045 epithelial fluid transport 3.753E-3 4.641E-2
3.292E-1
1.000E0
 1 7
50 GO:0010193 response to ozone 3.753E-3 4.641E-2
3.292E-1
1.000E0
 1 7
Show 45 more annotations

3: GO: Cellular Component [Display Chart] 10 input genes in category / 37 annotations before applied cutoff / 19061 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 GO:0005791 rough endoplasmic reticulum 1.011E-3 2.538E-2
1.066E-1
 3.741E-2 2 92
2 GO:0048237 rough endoplasmic reticulum lumen 2.621E-3 2.538E-2
1.066E-1
9.697E-2
 1 5
3 GO:0033093 Weibel-Palade body 2.621E-3 2.538E-2
1.066E-1
9.697E-2
 1 5
4 GO:0005741 mitochondrial outer membrane 3.434E-3 2.538E-2
1.066E-1
1.271E-1
 2 171
5 GO:0031968 organelle outer membrane 4.484E-3 2.538E-2
1.066E-1
1.659E-1
 2 196
6 GO:0043209 myelin sheath 4.755E-3 2.538E-2
1.066E-1
1.759E-1
 2 202
7 GO:0019867 outer membrane 4.801E-3 2.538E-2
1.066E-1
1.776E-1
 2 203
Show 2 more annotations

4: Human Phenotype [Display Chart] 7 input genes in category / 332 annotations before applied cutoff / 4707 genes in category

No results to display

5: Mouse Phenotype [Display Chart] 9 input genes in category / 421 annotations before applied cutoff / 10355 genes in category

No results to display

6: Domain [Display Chart] 10 input genes in category / 59 annotations before applied cutoff / 18735 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 IPR023217 Mucin-1 InterPro 5.338E-4 6.295E-3 2.936E-2 3.149E-2 1 1
2 IPR021629 Mediator Med23 InterPro 5.338E-4 6.295E-3 2.936E-2 3.149E-2 1 1
3 PF11573 Med23 Pfam 5.338E-4 6.295E-3 2.936E-2 3.149E-2 1 1
4 IPR008103 KiSS 1 rcpt InterPro 5.338E-4 6.295E-3 2.936E-2 3.149E-2 1 1
5 PS01220 PBP PROSITE 1.067E-3 6.295E-3 2.936E-2
6.297E-2
 1 2
6 IPR001858 Phosphotidylethanolamine-bd CS InterPro 1.067E-3 6.295E-3 2.936E-2
6.297E-2
 1 2
7 IPR020475 Bibrotoxin/Sarafotoxin-D InterPro 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
8 IPR001928 Endothln-like toxin InterPro 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
9 3.90.280.10 - Gene3D 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
10 IPR019764 Endothelin toxin CS InterPro 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
11 PF00322 Endothelin Pfam 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
12 SM00272 END SMART 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
13 IPR008914 PEBP InterPro 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
14 PF01161 PBP Pfam 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
15 PS00270 ENDOTHELIN PROSITE 1.601E-3 6.295E-3 2.936E-2
9.443E-2
 1 3
16 IPR023005 Nucleoside diP kinase AS InterPro 2.666E-3 9.832E-3 4.585E-2
1.573E-1
 1 5
17 PF03736 EPTP Pfam 3.199E-3 1.048E-2 4.888E-2
1.887E-1
 1 6
18 IPR005492 EPTP InterPro 3.199E-3 1.048E-2 4.888E-2
1.887E-1
 1 6
19 IPR011061 Hirudin/antistatin InterPro 3.731E-3 1.048E-2 4.888E-2
2.201E-1
 1 7
20 PS50912 EAR PROSITE 3.731E-3 1.048E-2 4.888E-2
2.201E-1
 1 7
21 IPR009039 EAR InterPro 3.731E-3 1.048E-2 4.888E-2
2.201E-1
 1 7
22 PS00469 NDP KINASES PROSITE 4.795E-3 1.286E-2
5.996E-2
2.829E-1
 1 9
23 SM00562 NDK SMART 5.326E-3 1.309E-2
6.106E-2
3.142E-1
 1 10
24 PF00334 NDK Pfam 5.326E-3 1.309E-2
6.106E-2
3.142E-1
 1 10
25 IPR001564 Nucleoside diP kinase InterPro 6.388E-3 1.508E-2
7.030E-2
3.769E-1
 1 12
26 SM00200 SEA SMART 7.449E-3 1.690E-2
7.883E-2
4.395E-1
 1 14
27 3.30.70.960 - Gene3D 7.980E-3 1.744E-2
8.131E-2
4.708E-1
 1 15
28 IPR011013 Gal mutarotase SF dom InterPro 9.039E-3 1.905E-2
8.882E-2
5.333E-1
 1 17
29 PS00282 KAZAL 1 PROSITE 9.569E-3 1.947E-2
9.078E-2
5.645E-1
 1 18
30 IPR018503 Tetraspanin CS InterPro 1.116E-2 2.183E-2
1.018E-1
6.582E-1
 1 21
31 PF01390 SEA Pfam 1.168E-2 2.183E-2
1.018E-1
6.893E-1
 1 22
32 PS50024 SEA PROSITE 1.221E-2 2.183E-2
1.018E-1
7.205E-1
 1 23
33 IPR000082 SEA dom InterPro 1.221E-2 2.183E-2
1.018E-1
7.205E-1
 1 23
34 PS00421 TM4 1 PROSITE 1.379E-2 2.394E-2
1.116E-1
8.139E-1
 1 26
35 IPR000301 Tetraspanin InterPro 1.695E-2 2.644E-2
1.233E-1
1.000E0
 1 32
36 IPR008952 Tetraspanin EC2 InterPro 1.695E-2 2.644E-2
1.233E-1
1.000E0
 1 32
37 PF01463 LRRCT Pfam 1.695E-2 2.644E-2
1.233E-1
1.000E0
 1 32
38 IPR018499 Tetraspanin/Peripherin InterPro 1.748E-2 2.644E-2
1.233E-1
1.000E0
 1 33
39 PF00335 Tetraspannin Pfam 1.748E-2 2.644E-2
1.233E-1
1.000E0
 1 33
40 PS51421 RAS PROSITE 1.853E-2 2.733E-2
1.275E-1
1.000E0
 1 35
41 PF07648 Kazal 2 Pfam 1.905E-2 2.742E-2
1.279E-1
1.000E0
 1 36
42 IPR020849 Small GTPase Ras InterPro 1.958E-2 2.750E-2
1.283E-1
1.000E0
 1 37
43 SM00280 KAZAL SMART 2.429E-2 3.333E-2
1.554E-1
1.000E0
 1 46
44 PS51465 KAZAL 2 PROSITE 2.638E-2 3.527E-2
1.644E-1
1.000E0
 1 50
45 IPR002350 Kazal dom InterPro 2.690E-2 3.527E-2
1.644E-1
1.000E0
 1 51
Show 40 more annotations

7: Pathway [Display Chart] 10 input genes in category / 132 annotations before applied cutoff / 12450 genes in category

No results to display

8: Pubmed [Display Chart] 10 input genes in category / 3099 annotations before applied cutoff / 38193 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 19951590 Expression of nm23, KAI1 and spiral computed tomography findings in primary gallbladder carcinoma. Pubmed 6.170E-8 6.374E-5 5.492E-4 1.912E-4 2 2
2 29187211 Roles of KAI1 and nm23 in lymphangiogenesis and lymph metastasis of laryngeal squamous cell carcinoma. Pubmed 6.170E-8 6.374E-5 5.492E-4 1.912E-4 2 2
3 19024519 [Expression of nm23 and KAI1 and their clinical significance in gallbladder adenocarcinoma]. Pubmed 6.170E-8 6.374E-5 5.492E-4 1.912E-4 2 2
4 23553196 The expression of BRCA1, P53, KAI1, and Nm23 in ovaries of BRCA1 mutation carriers after prophylactic adnexectomy. Pubmed 3.701E-7 2.294E-4 1.976E-3 1.147E-3 2 4
5 17283532 [Relationship between the expressions of KaI1, nm23, ETS-1, VEGF and microvascular density and clinical significance in nasopharyngeal carcinoma]. Pubmed 3.701E-7 2.294E-4 1.976E-3 1.147E-3 2 4
6 15592684 Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases. Pubmed 6.167E-7 3.185E-4 2.745E-3 1.911E-3 2 5
7 19199708 Proteomic analysis of human parotid gland exosomes by multidimensional protein identification technology (MudPIT). Pubmed 1.454E-4 5.565E-4 4.795E-3
4.507E-1
 3 416
8 17978050 The role of kisspeptin-GPR54 signaling in the tonic regulation and surge release of gonadotropin-releasing hormone/luteinizing hormone. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
9 10221345 Responses of blood pressure and catecholamine metabolism to high salt loading in endothelin-1 knockout mice. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
10 26638464 [PATIENTS WITH HAVE A LEVEL OF ENDOTHELIN-1 AN ANTIFOSFOLIPID SYNDROME: CONNECTION IS WITH MOTION OF DISEASE, DISFUNCTION OF ENDOTHELIA AND ATHEROSCLEROSIS]. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
11 12601555 Isolation and characterization of a novel human NM23-H1B gene, a different transcript of NM23-H1. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
12 20452970 Endothelin-1 (ET-1) increases the expression of remodeling genes in vascular smooth muscle through linked calcium and cAMP pathways: role of a phospholipase A(2)(cPLA(2))/cyclooxygenase-2 (COX-2)/prostacyclin receptor-dependent autocrine loop. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
13 23828675 Are Lewis b and H type 1 on Helicobacter pylori involved in binding of bacteria to MUC1 mucin? Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
14 14523636 Urinary excretion of endothelin-1 in children with absorptive idiopathic hypercalciuria. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
15 20635898 MUC1 immunotherapy. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
16 21253760 MUC1 expression in thymic epithelial tumors: MUC1 may be useful marker as differential diagnosis between type B3 thymoma and thymic carcinoma. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
17 23651915 Hyperactive behavior in a family with autosomal dominant lateral temporal lobe epilepsy caused by a mutation in the LGI1/epitempin gene. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
18 18676749 Genetic polymorphisms of metastasis suppressor gene NME1 and breast cancer survival. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
19 19656997 Effect of expressional alteration of KAI1 on breast cancer cell growth, adhesion, migration and invasion. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
20 14634722 The effect of cyclosporin A on the level of big endothelin in patients one year after orthotopic heart transplantation. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
21 16936258 Inflammatory murine skin responses to UV-B light are partially dependent on endothelin-1 and mast cells. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
22 18945274 Involvement of endothelin-1 in habitual exercise-induced increase in arterial compliance. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
23 26910281 Genetic variant rs4072037 of MUC1 and gastric cancer risk in an Eastern Chinese population. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
24 23103494 Taming the "sleeping giant": the role of endothelin-1 in the regulation of skeletal muscle blood flow and arterial blood pressure during exercise. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
25 12684410 KAI1 metastasis suppressor protein is down-regulated during the progression of human endometrial cancer. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
26 21498707 The endothelin axis in the metastatic process of colon carcinoma. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
27 28822766 Pseudomonas aeruginosa increases MUC1 expression in macrophages through the TLR4-p38 pathway. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
28 25016214 Endothelin-1 driven proliferation of pulmonary arterial smooth muscle cells is c-fos dependent. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
29 21323961 Increased mucin 1 expression in recurrence and malignant transformation of salivary gland pleomorphic adenoma. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
30 25597354 Raf kinase inhibitory protein (RKIP) as a metastasis suppressor: regulation of signaling networks in cancer. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
31 9153073 Physiological role of brain endothelin in the central autonomic control: from neuron to knockout mouse. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
32 26558823 Human Intestinal Raf Kinase Inhibitor Protein (RKIP) Catalyzes Prasugrel as a Bioactivation Hydrolase. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
33 17030190 Loss of Raf kinase inhibitor protein promotes cell proliferation and migration of human hepatoma cells. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
34 26238523 Effect of Raf kinase inhibitor protein expression on malignant biological behavior and progression of colorectal cancer. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
35 25234641 Glutamatergic neuron-targeted loss of LGI1 epilepsy gene results in seizures. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
36 18401297 Retinal detachment: visual acuity and subretinal immunoreactive endothelin-1. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
37 17292798 Raf kinase inhibitory protein knockout mice: expression in the brain and olfaction deficit. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
38 18172264 Node-negative colorectal cancer at high risk of distant metastasis identified by combined analysis of lymph node status, vascular invasion, and Raf-1 kinase inhibitor protein expression. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
39 12746758 Endothelin-1 levels in patients with disorders of the thyroid gland. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
40 25091456 Increased expression of MUC1 and sialyl Lewis antigens in different areas of clear renal cell carcinoma. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
41 24460302 Lack of association of common polymorphisms in MUC1 gene with H. pylori infection and non-cardia gastric cancer risk in a Chinese population. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
42 29508517 Generation and characterization of a mouse line carrying Reck-CreERT2 knock-in allele. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
43 19701204 Arrested maturation of excitatory synapses in autosomal dominant lateral temporal lobe epilepsy. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
44 20406885 MUC1 regulates nuclear localization and function of the epidermal growth factor receptor. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
45 12459174 Endothelin-1 is a potent stimulator of alpha1beta1 integrin-mediated collagen matrix remodeling by rat mesangial cells. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
46 17328840 The influence of three endothelin-1 polymorphisms on the progression of IgA nephropathy. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
47 16925492 MUC1 cytoplasmic tail: a potential therapeutic target for ovarian carcinoma. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
48 24969188 Effect of hemodialysis on pulmonary function tests and plasma endothelin levels. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
49 29053969 PEBP1 Wardens Ferroptosis by Enabling Lipoxygenase Generation of Lipid Death Signals. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
50 25757505 MUC1/SEC and MUC1/Y overexpression is associated with inflammation in Sjögren's syndrome. Pubmed 2.618E-4 5.565E-4 4.795E-3
8.114E-1
 1 1
Show 45 more annotations

9: Interaction [Display Chart] 10 input genes in category / 457 annotations before applied cutoff / 17703 genes in category

No results to display

10: Cytoband [Display Chart] 10 input genes in category / 10 annotations before applied cutoff / 34661 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 6q22.33-q24.1 6q22.33-q24.1 2.885E-4 2.885E-3 8.450E-3 2.885E-3 1 1
2 6p24.1 6p24.1 3.457E-3 1.439E-2 4.215E-2 3.457E-2 1 12
3 17q21.3 17q21.3 4.607E-3 1.439E-2 4.215E-2 4.607E-2 1 16
4 12q24.23 12q24.23 5.756E-3 1.439E-2 4.215E-2
5.756E-2
 1 20
5 10q24 10q24 1.005E-2 2.011E-2
5.889E-2
1.005E-1
 1 35
6 9p13.3 9p13.3 2.200E-2 3.314E-2
9.707E-2
2.200E-1
 1 77
7 11p11.2 11p11.2 2.510E-2 3.314E-2
9.707E-2
2.510E-1
 1 88
8 1q21 1q21 2.651E-2 3.314E-2
9.707E-2
2.651E-1
 1 93
Show 3 more annotations

11: Transcription Factor Binding Site [Display Chart] 7 input genes in category / 81 annotations before applied cutoff / 9770 genes in category

No results to display

12: Gene Family [Display Chart] 6 input genes in category / 7 annotations before applied cutoff / 18194 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 220 Peptide receptors genenames.org 2.307E-3 1.038E-2 2.691E-2 1.615E-2 1 7
2 961 NME/NM23 family genenames.org 2.965E-3 1.038E-2 2.691E-2 2.075E-2 1 9
3 471 CD molecules|Tumor necrosis factor superfamily genenames.org 6.623E-3 1.209E-2 3.134E-2 4.636E-2 2 394
4 648 Mucins genenames.org 6.906E-3 1.209E-2 3.134E-2 4.834E-2 1 21
5 1061 Mediator complex genenames.org 1.083E-2 1.264E-2 3.278E-2
7.584E-2
 1 33
6 768 Tetraspanins genenames.org 1.083E-2 1.264E-2 3.278E-2
7.584E-2
 1 33
Show 1 more annotation

13: Coexpression [Display Chart] 10 input genes in category / 1303 annotations before applied cutoff / 23137 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 15318170-Table4 Human Lung Joseph04 14genes GeneSigDB 1.526E-5 1.310E-2
1.015E-1
 1.988E-2 2 14
2 15361855-Table3 Human Ovarian Donninger04 19genes GeneSigDB 2.011E-5 1.310E-2
1.015E-1
 2.620E-2 2 16
3 15318170-Table1 Human Lung Joseph04 32genes GeneSigDB 7.267E-5 2.530E-2
1.961E-1
9.468E-2
 2 30
4 M1674 Genes up-regulated in H460 cells (non-small cell lung carcinoma, NSCLC) after treatment with sodium butyrate [PubChem=5222465]. MSigDB C2: CGP Curated Gene Sets (v6.0) 7.766E-5 2.530E-2
1.961E-1
1.012E-1
 2 31
5 19204204-SupplementaryTable7 Human Breast Parker09 306genes IntrinsicGenes HuShort GeneSigDB 1.285E-4 3.266E-2
2.531E-1
1.674E-1
 3 242
6 12687021-Figure1 Human Lung Kikuchi03 50genes GeneSigDB 1.504E-4 3.266E-2
2.531E-1
1.960E-1
 2 43
7 M6562 Genes up-regulated by 2-methoxyestradiol (2ME2) [PubChem=1573] in the MM.1S cell line (multiple myeloma) sensitive to dexamethasone [PubChem=5743]. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.120E-4 3.945E-2
3.058E-1
2.762E-1
 2 51
8 20103679-ST3-B Human Breast Wood10 416genes GeneSigDB 2.469E-4 3.972E-2
3.078E-1
3.217E-1
 3 302
9 M4737 ECM related genes up-regulated early (within 30 min) in dermal fibroblasts after addition of TGFB1 [GeneID=7040]. MSigDB C2: CGP Curated Gene Sets (v6.0) 2.744E-4 3.972E-2
3.078E-1
3.575E-1
 2 58
Show 4 more annotations

14: Coexpression Atlas [Display Chart] 10 input genes in category / 1127 annotations before applied cutoff / 21829 genes in category

No results to display

15: Computational [Display Chart] 7 input genes in category / 76 annotations before applied cutoff / 10037 genes in category

No results to display

16: MicroRNA [Display Chart] 10 input genes in category / 332 annotations before applied cutoff / 72241 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 hsa-miR-1298-5p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.458E-5 8.162E-3
5.210E-2
 8.162E-3 2 54
2 hsa-miR-664a-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 7.016E-5 1.165E-2
7.435E-2
 2.329E-2 2 91
3 hsa-miR-1294:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 1.082E-4 1.198E-2
7.647E-2
 3.594E-2 2 113
4 hsa-miR-5586-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.896E-4 1.743E-2
1.113E-1
9.614E-2
 2 185
5 hsa-miR-759:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 2.959E-4 1.743E-2
1.113E-1
9.822E-2
 2 187
6 hsa-miR-1470:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 3.151E-4 1.743E-2
1.113E-1
1.046E-1
 2 193
7 hsa-miR-4667-3p:Functional MTI (Weak) Functional MTI (Weak) miRTarbase 5.229E-4 2.349E-2
1.500E-1
1.736E-1
 2 249
8 hsa-miR-194:PITA hsa-miR-194:PITA TOP PITA 6.185E-4 2.349E-2
1.500E-1
2.054E-1
 2 271
9 hsa-miR-518c:mirSVR highEffct hsa-miR-518c:mirSVR nonconserved highEffect-0.5 MicroRNA.org 6.368E-4 2.349E-2
1.500E-1
2.114E-1
 2 275
10 hsa-miR-361-3p:mirSVR highEffct hsa-miR-361-3p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.003E-3 3.276E-2
2.091E-1
3.332E-1
 2 346
11 hsa-miR-95:mirSVR lowEffct hsa-miR-95:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 1.085E-3 3.276E-2
2.091E-1
3.603E-1
 2 360
12 hsa-miR-222-3p:Functional MTI Functional MTI miRTarbase 1.297E-3 3.415E-2
2.180E-1
4.306E-1
 2 394
13 hsa-miR-611:mirSVR lowEffct hsa-miR-611:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 1.591E-3 3.415E-2
2.180E-1
5.282E-1
 2 437
14 hsa-miR-3130-3p:mirSVR highEffct hsa-miR-3130-3p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 1.627E-3 3.415E-2
2.180E-1
5.402E-1
 2 442
15 hsa-miR-802:PITA hsa-miR-802:PITA TOP PITA 1.700E-3 3.415E-2
2.180E-1
5.645E-1
 2 452
16 hsa-miR-375:Functional MTI Functional MTI miRTarbase 1.890E-3 3.415E-2
2.180E-1
6.276E-1
 2 477
17 hsa-miR-219-5p:mirSVR highEffct hsa-miR-219-5p:mirSVR conserved highEffect-0.5 MicroRNA.org 1.906E-3 3.415E-2
2.180E-1
6.328E-1
 2 479
18 hsa-miR-3131:mirSVR lowEffct hsa-miR-3131:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 2.009E-3 3.415E-2
2.180E-1
6.670E-1
 2 492
19 hsa-miR-769-3p:mirSVR highEffct hsa-miR-769-3p:mirSVR nonconserved highEffect-0.5 MicroRNA.org 2.009E-3 3.415E-2
2.180E-1
6.670E-1
 2 492
20 hsa-miR-518b:mirSVR lowEffct hsa-miR-518b:mirSVR nonconserved lowEffect-0.1-0.5 MicroRNA.org 2.057E-3 3.415E-2
2.180E-1
6.831E-1
 2 498
Show 15 more annotations

17: Drug [Display Chart] 10 input genes in category / 3707 annotations before applied cutoff / 22841 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 ctd:C046783 11,12-epoxy-5,8,14-eicosatrienoic acid CTD 1.342E-5 3.062E-2
2.693E-1
 4.975E-2 2 13
2 CID000192866 1,2-diglyceride Stitch 5.099E-5 3.062E-2
2.693E-1
1.890E-1
 3 175
3 7389 UP 0173570-0000 [211245-44-2]; Up 200; 10uM; PC3; HT HG-U133A Broad Institute CMAP Up 6.016E-5 3.062E-2
2.693E-1
2.230E-1
 3 185
4 CID000123724 Bq 485 Stitch 6.020E-5 3.062E-2
2.693E-1
2.232E-1
 2 27
5 5813 UP Pyridoxine hydrochloride [58-56-0]; Up 200; 19.4uM; PC3; HT HG-U133A Broad Institute CMAP Up 7.035E-5 3.062E-2
2.693E-1
2.608E-1
 3 195
6 7244 UP Asiaticoside [16830-15-2]; Up 200; 4.2uM; PC3; HT HG-U133A Broad Institute CMAP Up 7.252E-5 3.062E-2
2.693E-1
2.688E-1
 3 197
7 ctd:C022884 undecane CTD 7.812E-5 3.062E-2
2.693E-1
2.896E-1
 3 202
8 CID000002948 damnacanthal Stitch 9.606E-5 3.062E-2
2.693E-1
3.561E-1
 2 34
9 ctd:D016593 Terfenadine CTD 1.019E-4 3.062E-2
2.693E-1
3.776E-1
 2 35
10 CID000004016 NSC-351907 Stitch 1.133E-4 3.062E-2
2.693E-1
4.200E-1
 3 229
11 CID005326871 LI 4 Stitch 1.203E-4 3.062E-2
2.693E-1
4.458E-1
 2 38
12 ctd:C121707 7,3'-dihydroxy-4'-methoxyisoflavone CTD 1.767E-4 3.062E-2
2.693E-1
6.551E-1
 2 46
13 CID000005832 norethisterone acetate Stitch 2.090E-4 3.062E-2
2.693E-1
7.747E-1
 2 50
14 CID000002399 BiM4 Stitch 2.117E-4 3.062E-2
2.693E-1
7.849E-1
 3 283
15 ctd:C055494 caffeic acid phenethyl ester CTD 2.875E-4 3.062E-2
2.693E-1
1.000E0
 3 314
16 CID003000505 f-Pt Stitch 3.536E-4 3.062E-2
2.693E-1
1.000E0
 2 65
17 CID000047528 nicorandil Stitch 4.219E-4 3.062E-2
2.693E-1
1.000E0
 2 71
18 ctd:D003033 Coal Tar CTD 4.362E-4 3.062E-2
2.693E-1
1.000E0
 3 362
19 DB03491 2'-Deoxyguanosine-5'-Diphosphate Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
20 CID000082280 propionate; acetate Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
21 ctd:C027278 urovision CTD 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
22 CID006450165 Aselacin A Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
23 CID000011336 Desderman Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
24 DB02181 2'-Deoxyguanosine-5'-Triphosphate Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
25 ctd:C087223 CGP 48369 CTD 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
26 CID000041103 IA-4-N-oxide Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
27 CID005378708 AC1NTDFJ Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
28 CID003081790 2-demethylsteffimycin D Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
29 DB02345 Selenocysteine Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
30 CID000083335 EPTP Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
31 CID006444270 Pepticinnamin E Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
32 ctd:C010210 lignoceric acid CTD 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
33 CID005492684 fusidienol Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
34 DB03103 Thymidine-5'- Diphosphate Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
35 CID003025826 L-731735 Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
36 DB02887 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Triphosphate Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
37 CID000154510 Ccris 4953 Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
38 CID000132953 Sch 49209 Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
39 CID000204808 2-phenylethanesulfonamide Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
40 CID000073702 ethanesulfonamide Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
41 DB04366 3'-Deoxy 3'-Amino Adenosine-5'-Diphosphate Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
42 CID000439911 AC1L98AL Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
43 DB02569 2',3'-Dehydro-2',3'-Deoxy-Thymidine 5'-Diphosphate Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
44 DB04542 3'-Azido-3'-Deoxythymidine-5'-Diphosphate Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
45 CID002758731 dodecyldimethylchlorosilane Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
46 CID000018384 phenoxyphenylacetic acid Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
47 DB04068 Fudp Drug Bank 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
48 CID000167621 2-oxododecanal Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
49 CID011030479 sodium zinc phosphate Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
50 CID000239061 xenaldial Stitch 4.378E-4 3.062E-2
2.693E-1
1.000E0
 1 1
Show 45 more annotations

18: Disease [Display Chart] 10 input genes in category / 692 annotations before applied cutoff / 16205 genes in category

ID Name Source pValue FDR B&H FDR B&Y Bonferroni Genes from Input Genes in Annotation
1 C1282496 Metastasis from malignant tumor of prostate DisGeNET BeFree 1.312E-7 6.344E-5 4.515E-4 9.076E-5 5 230
2 C0936223 Metastatic Prostate Carcinoma DisGeNET BeFree 1.833E-7 6.344E-5 4.515E-4 1.269E-4 5 246
3 C0278883 Metastatic melanoma DisGeNET BeFree 1.313E-6 3.029E-4 2.156E-3 9.086E-4 5 366
4 C0002963 Angina Pectoris, Variant DisGeNET BeFree 1.880E-5 3.252E-3 2.314E-2 1.301E-2 2 11
5 C0036220 Kaposi Sarcoma DisGeNET Curated 2.959E-5 4.096E-3 2.915E-2 2.048E-2 4 323
6 C0007138 Carcinoma, Transitional Cell DisGeNET Curated 4.427E-5 4.500E-3 3.203E-2 3.064E-2 4 358
7 C0024232 Lymphatic Metastasis DisGeNET Curated 5.677E-5 4.500E-3 3.203E-2 3.929E-2 3 129
8 C0278488 Carcinoma breast stage IV DisGeNET BeFree 6.184E-5 4.500E-3 3.203E-2 4.280E-2 4 390
9 C0010073 Coronary Artery Vasospasm DisGeNET Curated 6.474E-5 4.500E-3 3.203E-2 4.480E-2 2 20
10 C0004135 Ataxia Telangiectasia DisGeNET Curated 7.302E-5 4.500E-3 3.203E-2
5.053E-2
 4 407
11 C0027626 Neoplasm Invasiveness DisGeNET Curated 7.716E-5 4.500E-3 3.203E-2
5.340E-2
 3 143
12 C1704272 Benign Prostatic Hyperplasia DisGeNET BeFree 7.803E-5 4.500E-3 3.203E-2
5.400E-2
 4 414
13 C0346957 Disseminated Malignant Neoplasm DisGeNET BeFree 1.630E-4 8.675E-3
6.175E-2
1.128E-1
 3 184
14 C1135868 Gestational Trophoblastic Neoplasms DisGeNET BeFree 2.257E-4 9.030E-3
6.427E-2
1.562E-1
 2 37
15 C0085110 Severe Combined Immunodeficiency DisGeNET Curated 2.580E-4 9.030E-3
6.427E-2
1.785E-1
 3 215
16 C1134719 Invasive Ductal Breast Carcinoma DisGeNET Curated 2.580E-4 9.030E-3
6.427E-2
1.785E-1
 3 215
17 C0013274 Patent ductus arteriosus DisGeNET Curated 3.066E-4 9.030E-3
6.427E-2
2.122E-1
 3 228
18 C0333516 Tumor necrosis DisGeNET BeFree 3.351E-4 9.030E-3
6.427E-2
2.319E-1
 3 235
19 C2145472 Urothelial Carcinoma DisGeNET BeFree 3.478E-4 9.030E-3
6.427E-2
2.407E-1
 3 238
20 C0243050 Cardiovascular Abnormalities DisGeNET Curated 3.651E-4 9.030E-3
6.427E-2
2.526E-1
 2 47
21 C0006111 Brain Diseases DisGeNET Curated 3.925E-4 9.030E-3
6.427E-2
2.716E-1
 3 248
22 C0007124 Noninfiltrating Intraductal Carcinoma DisGeNET Curated 5.597E-4 9.030E-3
6.427E-2
3.873E-1
 3 280
23 cv:C1838062 Epilepsy, lateral temporal lobe, autosomal dominant Clinical Variations 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
24 C3553841 HYPOGONADOTROPIC HYPOGONADISM 8 WITH OR WITHOUT ANOSMIA DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
25 cv:CN143960 Hypogonadotropic hypogonadism 8 with or without anosmia Clinical Variations 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
26 cv:C1868139 Medullary cystic kidney disease 1 Clinical Variations 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
27 cv:C2748545 Question mark ears, isolated Clinical Variations 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
28 OMIN:176400 PRECOCIOUS PUBERTY, CENTRAL OMIM 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
29 C3805879 PRECOCIOUS PUBERTY, CENTRAL, 1 DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
30 C0156353 Uterovaginal prolapse DisGeNET BeFree 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
31 cv:C0342543 Central precocious puberty Clinical Variations 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
32 C4025730 Renal cortical atrophy DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
33 cv:C3280265 Mental retardation, autosomal recessive 18 Clinical Variations 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
34 cv:CN185375 Auriculocondylar syndrome 3 Clinical Variations 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
35 C3888103 Question mark ear DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
36 C0019937 Horner Syndrome DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
37 C0454578 Receptive aphasia (finding) DisGeNET BeFree 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
38 C1969371 Impaired renal uric acid clearance DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
39 C4023099 Elevated urinary dopamine DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
40 C0477728 Hereditary nephropathy DisGeNET BeFree 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
41 C1881236 Interstitial Disease DisGeNET BeFree 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
42 C0234461 aphasic DisGeNET BeFree 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
43 C4020736 Elevated urinary homovanillic acid DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
44 C2748545 QUESTION MARK EARS, ISOLATED DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
45 C3280265 MENTAL RETARDATION, AUTOSOMAL RECESSIVE 18 DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
46 C3810332 AURICULOCONDYLAR SYNDROME 3 DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
47 C4020735 Elevated urinary vanillylmandelic acid DisGeNET Curated 6.171E-4 9.030E-3
6.427E-2
4.270E-1
 1 1
48 C0008497 Choriocarcinoma DisGeNET BeFree 6.263E-4 9.030E-3
6.427E-2
4.334E-1
 3 291
49 C0279672 Cervical Adenocarcinoma DisGeNET BeFree 6.983E-4 9.861E-3
7.019E-2
4.832E-1
 2 65
50 C0850572 Adenomatous polyp of colon DisGeNET BeFree 7.418E-4 1.027E-2
7.307E-2
5.133E-1
 2 67
Show 45 more annotations